CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bangkok Genomics Innovation PCL is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bangkok Genomics Innovation PCL
Klongtoey, 3689 Rama 4 Phrakanong
BANGKOK, 10110  Thailand Ticker: BKGIBKGI
Business Summary
Bangkok Genomics Innovation Public Company Limited is a Thailand-based company. The Company operates a laboratory and provides medical diagnostic services. It provides genetic screening for individuals planning to have children and those experiencing infertility, such as preimplantation genetic testing for screening of embryonic abnormalities and screening for thalassemia carrier genes. Its infectious disease screening includes testing for human papillomavirus (HPV), which causes cervical cancer, monkeypox virus, coronavirus disease (COVID-19), and antibodies against COVID-19. Its screening tests predict the risk of developing hereditary cancers in individuals who have not yet developed the disease and used to monitor treatment and select medications appropriate to one's genetic makeup. Its genetic analysis decodes an individual's genetic makeup and allows for life planning in terms of diet, exercise, risk assessment for various genetic diseases, and application to anti-aging science.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025-----

Industries
SIC Code Description
8734 Testing laboratories
8093 Specialty outpatient facilities, not elsewhere classified

General Information
Number of Employees: 103 (As of 12/31/2024)
Outstanding Shares: 600,000,000 (As of 12/31/2025)
Stock Exchange: BAK


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, May 13, 2026